94 related articles for article (PubMed ID: 23337398)
1. Behavioural and anatomical characterization of mutant mice with targeted deletion of D1 dopamine receptor-expressing cells: response to acute morphine.
Babovic D; Jiang L; Goto S; Gantois I; Schütz G; Lawrence AJ; Waddington JL; Drago J
J Pharmacol Sci; 2013; 121(1):39-47. PubMed ID: 23337398
[TBL] [Abstract][Full Text] [Related]
2. Age-related behavioural phenotype and cellular characterisation of mice with progressive ablation of D1 dopamine receptor-expressing cells.
Babovic D; Jiang L; Gantois I; Lawrence AJ; Ferreri V; Schütz G; Waddington JL; Drago J
Behav Brain Res; 2010 Jan; 206(1):78-87. PubMed ID: 19733597
[TBL] [Abstract][Full Text] [Related]
3. Mutant mice lacking the cholecystokinin2 receptor show a dopamine-dependent hyperactivity and a behavioral sensitization to morphine.
Daugé V; Beslot F; Matsui T; Roques BP
Neurosci Lett; 2001 Jun; 306(1-2):41-4. PubMed ID: 11403953
[TBL] [Abstract][Full Text] [Related]
4. Motor and behavioral phenotype in conditional mutants with targeted ablation of cortical D1 dopamine receptor-expressing cells.
Jiang L; O'Leary C; Kim HA; Parish CL; Massalas J; Waddington JL; Ehrlich ME; Schütz G; Gantois I; Lawrence AJ; Drago J
Neurobiol Dis; 2015 Apr; 76():137-158. PubMed ID: 25684539
[TBL] [Abstract][Full Text] [Related]
5. Chronic morphine exposure and spontaneous withdrawal are associated with modifications of dopamine receptor and neuropeptide gene expression in the rat striatum.
Georges F; Stinus L; Bloch B; Le Moine C
Eur J Neurosci; 1999 Feb; 11(2):481-90. PubMed ID: 10051749
[TBL] [Abstract][Full Text] [Related]
6. Differences among mouse strains in the regulation by mu, delta 1 and delta 2 opioid receptors of striatal adenylyl cyclases activated by dopamine D1 or adenosine A2a receptors.
Noble F; Cox BM
Brain Res; 1996 Apr; 716(1-2):107-17. PubMed ID: 8738226
[TBL] [Abstract][Full Text] [Related]
7. Delayed, context- and dopamine D1 receptor-dependent activation of ERK in morphine-sensitized mice.
Borgkvist A; Valjent E; Santini E; Hervé D; Girault JA; Fisone G
Neuropharmacology; 2008 Aug; 55(2):230-7. PubMed ID: 18614186
[TBL] [Abstract][Full Text] [Related]
8. Dopamine D1 receptor-dependent modifications in the dopamine and cAMP-regulated phosphoprotein of Mr 32 kDa phosphorylation pattern in striatal areas of morphine-sensitized rats.
Scheggi S; Crociani A; De Montis MG; Tagliamonte A; Gambarana C
Neuroscience; 2009 Oct; 163(2):627-39. PubMed ID: 19559764
[TBL] [Abstract][Full Text] [Related]
9. Striatal dopamine receptors in rats displaying long-term behavioural sensitization to morphine.
Nestby P; Schotte A; Janssen PF; Tjon GH; Vanderschuren LJ; De Vries TJ; Mulder AH; Leysen JE; Schoffelmeer AN
Synapse; 1997 Nov; 27(3):262-5. PubMed ID: 9329160
[No Abstract] [Full Text] [Related]
10. Increased dopamine D2 receptor binding and enhanced apomorphine-induced locomotor activity in mu-opioid receptor knockout mice.
Tien LT; Park Y; Fan LW; Ma T; Loh HH; Ho IK
Brain Res Bull; 2003 Jun; 61(1):109-15. PubMed ID: 12788214
[TBL] [Abstract][Full Text] [Related]
11. Nucleus accumbens D2- and D1-receptor expressing medium spiny neurons are selectively activated by morphine withdrawal and acute morphine, respectively.
Enoksson T; Bertran-Gonzalez J; Christie MJ
Neuropharmacology; 2012 Jun; 62(8):2463-71. PubMed ID: 22410393
[TBL] [Abstract][Full Text] [Related]
12. Fasting biases μ-opioid receptors toward β-arrestin2-dependent signaling in the accumbens shell.
Scheggi S; Ferrari A; Pelliccia T; Devoto P; De Montis MG; Gambarana C
Neuroscience; 2017 Jun; 352():19-29. PubMed ID: 28391016
[TBL] [Abstract][Full Text] [Related]
13. Dopamine receptor D1 but not D3 essential for morphine-induced conditioned responses.
Wang YP; Wei SG; Zhu YS; Zhao B; Xun X; Lai JH
Genet Mol Res; 2015 Jan; 14(1):180-9. PubMed ID: 25729949
[TBL] [Abstract][Full Text] [Related]
14. Selective Vulnerability of Striatal D2 versus D1 Dopamine Receptor-Expressing Medium Spiny Neurons in HIV-1 Tat Transgenic Male Mice.
Schier CJ; Marks WD; Paris JJ; Barbour AJ; McLane VD; Maragos WF; McQuiston AR; Knapp PE; Hauser KF
J Neurosci; 2017 Jun; 37(23):5758-5769. PubMed ID: 28473642
[TBL] [Abstract][Full Text] [Related]
15. Autoradiographic study of striatal dopamine re-uptake sites and dopamine D1 and D2 receptors in a 6-hydroxydopamine and quinolinic acid double-lesion rat model of striatonigral degeneration (multiple system atrophy) and effects of embryonic ventral mesencephalic, striatal or co-grafts.
Puschban Z; Scherfler C; Granata R; Laboyrie P; Quinn NP; Jenner P; Poewe W; Wenning GK
Neuroscience; 2000; 95(2):377-88. PubMed ID: 10658617
[TBL] [Abstract][Full Text] [Related]
16. Dopamine D1, D2 and mu-opioid receptors are co-expressed with adenylyl cyclase 5 and phosphodiesterase 7B mRNAs in striatal rat cells.
de Gortari P; Mengod G
Brain Res; 2010 Jan; 1310():37-45. PubMed ID: 19913519
[TBL] [Abstract][Full Text] [Related]
17. Striatal Distribution and Cytoarchitecture of Dopamine Receptor Subtype 1 and 2: Evidence from Double-Labeling Transgenic Mice.
Ren K; Guo B; Dai C; Yao H; Sun T; Liu X; Bai Z; Wang W; Wu S
Front Neural Circuits; 2017; 11():57. PubMed ID: 28860974
[TBL] [Abstract][Full Text] [Related]
18. Ablation of D1 dopamine receptor-expressing cells generates mice with seizures, dystonia, hyperactivity, and impaired oral behavior.
Gantois I; Fang K; Jiang L; Babovic D; Lawrence AJ; Ferreri V; Teper Y; Jupp B; Ziebell J; Morganti-Kossmann CM; O'Brien TJ; Nally R; Schütz G; Waddington J; Egan GF; Drago J
Proc Natl Acad Sci U S A; 2007 Mar; 104(10):4182-7. PubMed ID: 17360497
[TBL] [Abstract][Full Text] [Related]
19. Ethological resolution of behavioural topography and D1-like versus D2-like agonist responses in congenic D5 dopamine receptor mutants: identification of D5:D2-like interactions.
O'Sullivan GJ; Kinsella A; Sibley DR; Tighe O; Croke DT; Waddington JL
Synapse; 2005 Mar; 55(4):201-11. PubMed ID: 15668951
[TBL] [Abstract][Full Text] [Related]
20. Ventral pallidal injections of a mu antagonist block the development of behavioral sensitization to systemic morphine.
Johnson PI; Napier TC
Synapse; 2000 Oct; 38(1):61-70. PubMed ID: 10941141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
